MedPath

TARO-BUPROPION XL

TARO-BUPROPION XL

Approved
DIN Number

02475812

Drug Class

Human

Market Date

May 15, 2019

Company
HC

sun pharma canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02475812
AIG Number0131140004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AX12 BUPROPION
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification28:16.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

BUPROPION HYDROCHLORIDEActive
Strength: 300 MG
Monograph: BUPROPION HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.